Demand is soaring for its memory products.

Serge Saxonov, Chief Executive Officer of 10x Genomics (NASDAQ:TXG), reported the direct sale of 28,893 shares of Common Stock in multiple open-market transactions between May 22 and May 26, 2026, ...

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...

Rigetti Computing’s stock jumped 30% on July 16 after reaching 99.5% gate fidelity on its 36-qubit modular system—halving error rates compared to its earlier 84 ...

On May 12, 2026, Quantedge Capital disclosed in a Securities and Exchange Commission (SEC) filing that it bought 212,600 shares of 10x Genomics (NASDAQ:TXG), an estimated $4.25 million transaction ...

One potential explanation is that the volume of loans held on Upstart's balance sheet grew by 25% sequentially to more than $1 billion, adding a bit of default risk, but even this doesn't justify such ...

10x Genomics (TXG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates - ...